CONTROL OF INTERLEUKIN-2 IN SJOGREN'S SYNDROME

干燥综合征中白细胞介素 2 的控制

基本信息

  • 批准号:
    2130501
  • 负责人:
  • 金额:
    $ 13.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-07-01 至 1996-08-31
  • 项目状态:
    已结题

项目摘要

Sjogren's syndrome (SS) is characterized by lymphocytic infiltration of the salivary glands leading to a variety of dental complications. This project focuses on molecular abnormalities in IL-2 biology involving SS T cells. T lymphocytes from SS peripheral blood are hyporesponsive to mitogenic and antigenic stimuli, whereas T lymphocytes infiltrating the SS salivary glands actively produce IL-2. Some of these are older observations based on cell activation markers; others are recent findings from our own laboratory measuring transcription factors or using PCR amplification in SS salivary gland tissue. The current specific aims which follow are designed to further analyze abnormalities of signal transduction in relation to a defect in the Oct. 1 transcription factor necessary for IL-2 gene activation, to continue our analysis of cytokine profiles using PCR, and to develop new therapeutic modalities for SS. Specific aims: 1. The expression of nuclear proteins binding to cognate DNA sequences in the IL-2 gene promoter region (transcription factors) will be assessed by electrophoretic mobility shift assay. This signaling event is putatively the most distal in the pathway. Therefore, abnormalities detected would support our hypothesis that an early signaling defect in calcium contributes to the reduced biosynthesis of IL-2. 2. Specific mRNAs for the gene encoding IL-2 will be studied in SS salivary glands using the PCR. Demonstration of inflammatory cytokines such as IL-2 in SS tissues could provide an explanation for the intense lymphocytic infiltration and tissue destruction. 3. Normalization of IL-2 biosynthesis, as well as the expression of proteins involved in the regulation of the IL-2 gene, will be attempted using drugs known to enhance T cell activation. Aspirin-like drugs that enhance L-2 production and both early and late signaling events will be studied.
干燥综合征(SS)以淋巴细胞浸润为特征

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NORMAN TALAL其他文献

NORMAN TALAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NORMAN TALAL', 18)}}的其他基金

REGULATION OF INFLAMMATORY CYTOKINES IN SJOGREN'S SYNDROME SALIVARY GLANDS
干燥综合征唾液腺炎症细胞因子的调节
  • 批准号:
    6104879
  • 财政年份:
    1998
  • 资助金额:
    $ 13.32万
  • 项目类别:
REGULATION OF INFLAMMATORY CYTOKINES IN SJOGREN'S SYNDROME SALIVARY GLANDS
干燥综合征唾液腺炎症细胞因子的调节
  • 批准号:
    6238550
  • 财政年份:
    1997
  • 资助金额:
    $ 13.32万
  • 项目类别:
ORAL HEALTH AND IMMUNE STATUS IN SJOGRENS SYNDROME
干燥综合征的口腔健康和免疫状态
  • 批准号:
    2131781
  • 财政年份:
    1994
  • 资助金额:
    $ 13.32万
  • 项目类别:
ORAL HEALTH AND IMMUNE STATUS IN SJOGRENS SYNDROME
干燥综合征的口腔健康和免疫状态
  • 批准号:
    2131780
  • 财政年份:
    1994
  • 资助金额:
    $ 13.32万
  • 项目类别:
CONTROL OF INTERLEUKIN-2 IN SJOGREN'S SYNDROME
干燥综合征中白细胞介素 2 的控制
  • 批准号:
    3223102
  • 财政年份:
    1990
  • 资助金额:
    $ 13.32万
  • 项目类别:
INTERLEUKIN-2 PRODUCTION IN SJOGREN'S SYNDROME
干燥综合征中白细胞介素 2 的产生
  • 批准号:
    3223103
  • 财政年份:
    1990
  • 资助金额:
    $ 13.32万
  • 项目类别:
INTERLEUKIN-2 PRODUCTION IN SJOGREN'S SYNDROME
干燥综合征中白细胞介素 2 的产生
  • 批准号:
    3223101
  • 财政年份:
    1990
  • 资助金额:
    $ 13.32万
  • 项目类别:
INTERLEUKIN-2 PRODUCTION IN SJOGREN'S SYNDROME
干燥综合征中白细胞介素 2 的产生
  • 批准号:
    3223104
  • 财政年份:
    1990
  • 资助金额:
    $ 13.32万
  • 项目类别:
SJOGREN'S SYNDROME SYMPOSIUM
干燥综合症研讨会
  • 批准号:
    3433730
  • 财政年份:
    1988
  • 资助金额:
    $ 13.32万
  • 项目类别:
MULTIPURPOSE ARTHRITIS CENTER
多功能关节炎中心
  • 批准号:
    3108143
  • 财政年份:
    1985
  • 资助金额:
    $ 13.32万
  • 项目类别:

相似海外基金

Exploring Roles for Transcription Factor Ets1 in Sjogren's Syndrome
探索转录因子 Ets1 在干燥综合征中的作用
  • 批准号:
    10644080
  • 财政年份:
    2023
  • 资助金额:
    $ 13.32万
  • 项目类别:
Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome
衰老和氧化应激对干燥综合征唾液腺疾病的影响
  • 批准号:
    10682148
  • 财政年份:
    2023
  • 资助金额:
    $ 13.32万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10854472
  • 财政年份:
    2023
  • 资助金额:
    $ 13.32万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10528045
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
利用分子特征为干燥综合征提供个性化 B 细胞靶向治疗
  • 批准号:
    MR/X004694/1
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
    Research Grant
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10646349
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
Targeting Endogenous Mesenchymal Stromal Cells with Ruxolitinib to Treat Sialadenitis in Sjogren's Syndrome
用鲁索替尼靶向内源性间充质基质细胞治疗干燥综合征的唾液腺炎
  • 批准号:
    10524424
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10685136
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
Controlling Autoimmune Inflammation and Promoting Salivary Gland Regeneration in Sjogren's Syndrome
控制干燥综合征的自身免疫炎症并促进唾液腺再生
  • 批准号:
    10657745
  • 财政年份:
    2022
  • 资助金额:
    $ 13.32万
  • 项目类别:
Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome
靶向 P2 受体以恢复干燥综合征患者的唾液腺和泪腺功能
  • 批准号:
    10554383
  • 财政年份:
    2021
  • 资助金额:
    $ 13.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了